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autonomic neurons, including those controlling the cardio-
vascular system, thermogenesis, and energy balance. Pre-
proglucagon (PPG) neurons, located mainly in the nucleus
tractus solitarius (NTS) and medullary reticular formation,
produceGLP-1. In transgenicmice expressing glucagon pro-
moter-driven yellow ﬂuorescent protein (YFP), these brain-
stem PPG neurons project to many central autonomic
regions where GLP-1 receptors are expressed. The spinal
cord also containsGLP-1 receptormRNAbut the distribution
of spinal PPG axons is unknown. Here, we used two-color
immunoperoxidase labeling to examine PPG innervation of
spinal segments T1–S4 in YFP-PPG mice. Immunoreactivity
for YFP identiﬁed spinal PPGaxons and perikarya.We classi-
ﬁed spinal neurons receiving PPG input by immunoreactivity
for choline acetyltransferase (ChAT), nitric oxide synthase
(NOS) and/or Fluorogold (FG) retrogradely transported from
the peritoneal cavity. FG microinjected at T9 deﬁned cell
bodies that supplied spinal PPG innervation. The deep dor-
sal hornof lower lumbarcordcontainedYFP-immunoreactive
neurons. Non-varicose, YFP-immunoreactive axons were
prominent in the lateral funiculus, ventral white commissure
and around the ventral median ﬁssure. In T1–L2, varicose,
YFP-containing axons closely apposedmanyChAT-immuno-
reactive sympathetic preganglionic neurons (SPN) in thehttp://dx.doi.org/10.1016/j.neuroscience.2014.10.043
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872intermediolateral cell column (IML) and dorsal lamina X. In
the sacral parasympathetic nucleus, about 10% of ChAT-
immunoreactive preganglionic neurons received YFP appo-
sitions, as did occasional ChAT-positive motor neurons
throughout the rostrocaudal extent of the ventral horn. YFP
appositions also occurred on NOS-immunoreactive spinal
interneurons and on spinal YFP-immunoreactive neurons.
Injecting FG at T9 retrogradely labeled many YFP-PPG cell
bodies in the medulla but none of the spinal YFP-immunore-
active neurons. These results show that brainstem PPG
neurons innervate spinal autonomic and somatic motor neu-
rons. The distributions of spinal PPGaxons and spinal GLP-1
receptors correlate well. SPN receive the densest PPG
innervation. BrainstemPPGneurons could directlymodulate
sympathetic outﬂow through their spinal inputs to SPN or
interneurons.  2014 The Authors. Published by Elsevier Ltd.
on behalf of IBRO. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/3.0/).
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protein, glucagon-like peptide-1, nucleus of the solitary tract,
parasympathetic preganglionic neurons, retrograde tracing.
INTRODUCTION
Glucagon-like peptide 1 (GLP-1) is released post-
prandially from enteroendocrine cells in the gut and
facilitates absorption of nutrients (Holst, 2007). GLP-1 is
also a potent satiety signal (Turton et al., 1996) and treat-
ment with GLP-1 analogs results in sustained weight loss
in humans (Drucker and Nauck, 2006; Buse et al., 2009;
Holst, 2013). Furthermore, studies using microinjections
of GLP-1 receptor antagonists into speciﬁc brain regions
in rodents indicate that, within the central nervous system
(CNS), endogenous GLP-1 can also produce satiety
(Hayes et al., 2009; Williams et al., 2009; Barrera et al.,
2011; Dossat et al., 2011; Alhadeﬀ et al., 2012).
In the CNS preproglucagon (PPG) is processed post-
translationally to produce GLP-1, GLP-2, and
oxyntomodulin (Holst, 2007). The highest levels of these
PPG products occur in the dorsomedial hypothalamus
(DMH) and hypothalamic paraventricular nucleus (PVN)
and the lowest levels are found in the cortex and hindbrain
(Jin et al., 1988; Vrang et al., 2007; Tauchi et al., 2008).
The medulla oblongata contains most of the brain’s GLP-
1-synthesizing neurons. The majority of GLP-1-producing
somata in the brainstem occur in the caudal nucleus trac-
tus solitarius (NTS). Some GLP-1 cell bodies are also
located in the dorsomedial region of the medullary reticular
nucleus (Jin et al., 1988; Larsen et al., 1997). Retrograde/licenses/by/3.0/).
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mus arise from these two subgroups of GLP-1 neurons
(Larsen et al., 1997; Vrang et al., 2007). Consistent with
these immunocytochemical data, the only brain regions
that contain detectable levels of PPGmRNAare the caudal
NTS, the intermediate reticular nucleus (IRT) and the
olfactory bulb (Merchenthaler et al., 1999). Using trans-
genic mice in which expression of yellow ﬂuorescent pro-
tein (YFP) is controlled by the glucagon promoter
(Reimann et al., 2008), we have previously described the
full distribution of PPG cell bodies and dendrites within
the medulla and shown widespread GLP-1 innervation
throughout the brain (Llewellyn-Smith et al., 2011). This
distribution of YFP-PPG axons within the brain parallels
the distribution of brain GLP-1 receptors (Shughrue
et al., 1996; Merchenthaler et al., 1999). Taken together,
these anatomical ﬁndings suggest that GLP-1 release from
PPG axons within the brain could inﬂuence homeostatic
responses and help to coordinate energy balance, food
intake and cardiovascular function.
More recently, we have demonstrated that PPG
neurons directly innervate cranial parasympathetic
preganglionic neurons in the dorsal motor nucleus of the
vagus (DMV), again using YFP-PPG mice (Llewellyn-
Smith et al., 2013). We also showed that populations of
ventral medullary neurons that have been implicated in
central sympathetic control received PPG input. Although
the spinal cord has not yet been examined for the pres-
ence of PPG mRNA, perikarya expressing mRNA for
GLP-1 receptors occur in laminae V–X throughout the
rat spinal cord (Merchenthaler et al., 1999). Hence, our
observations raised the possibility that GLP-1 neurons
in the brainstem might also provide direct input to spinal
autonomic neurons.
Here, we demonstrate that there is GLP-1 innervation of
neurons in the spinal cord that contain immunoreactivity for
the enzymes that synthesize acetylcholine and nitric oxide.
As in previous work (Hisadome et al., 2010; Llewellyn-
Smith et al., 2011, 2013), we used transgenic YFP-PPG
mice in order to take advantage of the strong YFP expres-
sion that occurs throughout the cytoplasm of PPG neurons,
including their terminals. We detected spinal PPG axons by
the presence of YFP-immunoreactivity and identiﬁed their
innervation targets using immunoreactivity for choline ace-
tyltransferase (ChAT), nitric oxide synthase (NOS), and/or
Fluorogold (FG) retrogradely transported from the perito-
neal cavity. We determined the source of the spinal GLP-1
innervationby retrograde transport ofFG from injections into
thoracic (T) spinal segment T9.
EXPERIMENTAL PROCEDURES
All experiments were carried out in accordancewith the UK
Animals (Scientiﬁc Procedures) Act, 1986 and had the
required ethics approvals. We used a total of 21 adult
mGLU-124 Venus YFPmice (Reimann et al., 2008), which
we call YFP-PPG mice here. Bred at Imperial College, the
13 male and eight female mice received food and water ad
libitum andwere kept on a 12-h light:12-h dark cycle.When
perfused at 12–16 weeks after birth, the mice weighed
25–35 g, with females being lighter thanmales of the same
age.Retrograde tracing with FGIntraperitoneal injections. Three male YFP-PPG mice
had FG (0.2% in distilled water, 40 ll) injected into the
peritoneal cavity as in Anderson and Edwards (1994).
Spinal injections. Three male and two female YFP-
PPG mice were anesthetized with ketamine (75 mg/kg;
i.m.) and medetomidine (0.3 mg/kg; i.m.) and placed in a
stereotaxic frame. The thoracic spinal cord (segment T9)
was carefully exposed by retracting the intervertebral
space between vertebrae T6–T7 followed by removal of
the yellow ligament. The dura mater was pierced with a
19-g needle and the intermediolateral cell column (IML)
was unilaterally targeted with a microinjection of FG (2%,
50 nl) placed 0.2 mm lateral to the midline and 0.5 mm
ventral from the dorsal surface of the spinal cord.
Anesthesia was reversed with atipamezol (1 mg/kg; i.m.)
and postoperative analgesia was given for 4 days
(buprenorphine, 1 mg/kg). Mice recovered normally
without abnormalities in locomotion. All mice with FG
injections were perfused transcardially 7 days after
surgery. Correct targeting of the area with FG and its
spread within the spinal cord was conﬁrmed postmortem
by analysis of spinal cord sections immunoperoxidase
stained for FG.Perfusion and tissue preparation
YFP-PPG mice under ketamine and medetomidine
anesthesia were heparinized (500 IU/l) and their blood
was removed with a ﬂush of phosphate-buﬀered saline.
The mice were then transcardially perfused with 60 ml of
phosphate-buﬀered 4% formaldehyde. After 3 days of
post-ﬁxation, brains and spinal cords still in their vertebral
columns were shipped to Flinders for sectioning and
immunohistochemical processing.
Spinal cords were removed from their vertebral
columns, post-ﬁxed at room temperature on a shaker for
2–3 days in phosphate-buﬀered 4% formaldehyde and
then divided into segments. The rostral edge of the dorsal
root entry zone was considered to mark the rostral
boundary of each segment. For horizontal sections, cords
from two male YFP-PPG mice were divided into three
lengths (T1–T7, T8–L3 and L4–S4). For transverse
sectioning, thoracic and upper lumbar cords from 19 mice
were divided into T1–3 and then two-segment length
blocks through to segment L3; segments L4–S4 were left
as one piece. The blocks containing T1–L3 from each
mouse were embedded together in albumin gelatine
(Llewellyn-Smith et al., 2007) to form a single block. Seg-
ments L4–S4 from two to three mice were embedded
together in a single block of albumin gelatine. The albumin
gelatine blocks for transverse sectioning and the cord
lengths for horizontal sectioning were inﬁltrated with 20%
then 30% sucrose. Blocks for transverse sectioning were
cut at 25 lm on a cryostat. Cord segments for horizontal
cryostat sections were cut at 30 lm.
The medullas of mice with injections of FG at T9 were
blocked without the use of a brain matrix, inﬁltrated with
sucrose and cut into three series of transverse 30-lm
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between blocks, we could not assign Bregma values to
brainstem sections.Immunohistochemistry
Cryostat sections were ﬁrst washed 3  10 min in 10 mM
Tris, 0.9% NaCl, 0.05% thimerosal in 10 mM phosphate
buﬀer, pH 7.4, (TPBS) containing 0.3% Triton X-100 for
removal of membranes and then exposed to TPBS-
Triton containing 10% normal horse serum (NHS) for at
least 30 min to block non-speciﬁc antibody binding.
Primary antibodies were diluted with TPBS-Triton
containing 10% NHS; secondary antibodies, with TPBS-
Triton containing 1% NHS; and the avidin-horseradish
peroxidase complex, with TPBS-Triton. All steps took
place at room temperature on a shaker and sections
were washed 3  10 min in TPBS after each incubation
in an immunoreagent.
The optimal dilutions of primary antibodies (Table 1)
were determined by titration and gave the maximum
number of immunoreactive structures with minimal non-
speciﬁc background staining. For optimally visualizing
the spinal axons of YFP-expressing neurons, the anti-
green ﬂuorescent protein (GFP) antibody was used
more dilute than for optimally visualizing their cell bodies
(see Llewellyn-Smith et al., 2011).Immunoperoxidase labeling. All antigens were
localized with a standard avidin–biotin-peroxidase
protocol and either black or brown diaminobenzidine
(DAB) reaction products. The sections that had been
washed in TPBS-Triton and exposed to 10% NHS as
above were transferred into the ﬁrst primary antibody for
2–5 days. After washing, sections were incubated
overnight in a biotinylated donkey anti-immunoglobulin
(Ig) antibody (1:500; Jackson ImmunoResearch, West
Grove PA) followed by a 4–6-h incubation in ExtrAvidin-
peroxidase (1:1500; Sigma–Aldrich, St Louis, MO,
USA). A cobalt + nickel-intensiﬁed DAB reaction in
which peroxide was generated by glucose oxidase
(Llewellyn-Smith et al., 2005) stained structures immuno-
reactive for the ﬁrst antigen black. After the ﬁrst antigen
had been localized with a black DAB reaction product,
the sections were washed and underwent another block-
ing step in NHS. Then the immunohistochemical protocol
above was repeated to localize the second antigen, which
was stained brown with an imidazole-intensiﬁed DAB
reaction with peroxide again produced by a glucose oxi-
dase reaction (Llewellyn-Smith et al., 2005).
Localization of the following combinations of antigens
revealed the innervation targets of spinal PPG axons:
YFP (black) + ChAT (brown); YFP (black) + NOS
(brown); YFP (black) + FG (black) + NOS (brown).
Immunostaining for FG (black) and YFP (brown) deﬁned
whether YFP-immunoreactive cell bodies in the dorsal
horn of lower lumbar cord sent axons rostrally through
FG injection sites in T9.
After immunoperoxidase staining, sections were
mounted in serial order onto chrome alum-gelatine-
coated slides, dried, cleared and coverslipped withPermaslip mounting medium (Alban Scientiﬁc, St Louis,
MO, USA).
Immunoﬂuorescence labeling. Double immunoﬂuo-
rescent labeling was performed on brainstem sections
from two female and three male YFP-PPG mice with FG
injections at T9. After washes in Tris-PBS-Triton and
exposure to 10% NHS, the sections were incubated in
anti-GFP (1:10,000) plus anti-FG (1:2000), then in FITC-
donkey anti-chicken IgY (1:200) plus biotinylated donkey
anti-guinea-pig IgG (1:500) and ﬁnally in Cy3-Streptavidin
(1:1000; Amersham catalog# PA43001; GE Healthcare
Bio-Sciences Pty. Ltd., Rydalmere, NSW, Australia).
Incubation times were the same as in the immuno-
peroxidase protocol. Buﬀered glycerol was used to mount
the immunoﬂuorescently stained sections in serial order.
Coverslips were applied and sealed with nail polish to
prevent dehydration. Slides were stored in the dark at
4 C until examination.
Antibody characterization. The chicken anti-GFP
antiserum used here speciﬁcally recognizes YFP. In
Llewellyn-Smith et al. (2011), we demonstrated that sec-
tions from animals lacking YFP-immunoreactivity showed
no labeling when stained with this antibody. Furthermore,
the antibody detected immunoreactivity in all of the brain-
stem neurons that showed native YFP ﬂuorescence.
We have previously characterized the Chemicon goat
anti-ChAT antiserum (Llewellyn-Smith et al., 2005, 2007).
Absorption of a 1:2000 dilution of this antiserum with
2 lg/ml recombinant rat ChAT abolished staining in
sections of similarly ﬁxed and processed tissue. Further-
more, cholinergic neurons visualized with this anti-ChAT
antiserum showed the expected spinal distribution
(Fenwick et al., 2006).
We have also characterized the ImmunoStar rabbit
anti-NOS antiserum (Hinrichs and Llewellyn-Smith,
2009). NOS immunoreactivity was not detectable when
we stained sections of formaldehyde-ﬁxed spinal cord
with 1:50,000 anti-NOS antiserum that had been
absorbed overnight with 0.5 lg/ml of control peptide.
The speciﬁcity of the Protos guinea-pig anti-FG
antibody was also deﬁned using overnight absorption
(Llewellyn-Smith et al., 2007). A 1:20,000 dilution of the
anti-FG antiserum preabsorbed with 10 lg/ml FG failed
to stain sections containing neurons retrogradely labeled
with FG.
Data collection and analysis
We used an Olympus BH-2 brightﬁeld microscope to
examine immunoperoxidase-stained sections containing
spinal segments T1–S4. Using a 100 oil immersion
lens, we determined whether close appositions from
black YFP-immunoreactive axon terminals occurred on
spinal neurons with brown immunoreactivity for ChAT
or NOS, brown NOS-immunoreactivity plus black
FG-immunoreactivity or black YFP-immunoreactivity. We
classed YFP terminals lying side-by-side with an
immunolabeled neuron as closely apposed when no
space separated the terminal and the neuron. Where
terminals crossed over immunoreactive neurons, an
Table 1. Antibodies used
Antigen Immunogen Manufacturer, species antibody was raised in,
mono- vs. polyclonal, catalog and lot number
Dilution used
Primary antibodies
Green ﬂuorescent protein (GFP) Recombinant full-length green ﬂuorescent protein Abcam (Cambridge, MA, USA), chicken
polyclonal, catalog # AB13970, lot # 623923
1:10,000b 1:50,000a 1:100,000a
Choline acetyltransferase (ChAT) Human placental choline acetyltransferase Chemicon (Temecula, CA, USA), goat polyclonal,
catalog # AB144P, lot # 18110644 or JC1669317
1:5,000a
Neuronal nitric oxide synthase (NOS) C-terminal synthetic peptide sequence
corresponding to amino acids 1419–1433 of
human neuronal NOS coupled to keyhole limpet
hemocyanin
ImmunoStar (Stillwater MN, USA), rabbit
polyclonal, catalog # 24287, lot # 043005
1:50,000a 1:150,000a
Fluorogold (FG) Glutaraldehyde conjugate of Fluorogold Protos Biotech Corporation (New York, NY, USA),




Biotinylated donkey anti-chicken IgY Catalog # 703-065-155; Jackson ImmunoResearch
(West Grove, PA, USA)
1:500
Biotinylated donkey anti-goat IgG Catalog # 705-065-147; Jackson ImmunoResearch
(West Grove, PA, USA)
1:500
Biotinylated donkey anti-rabbit IgG Catalog # 711-065-152; Jackson ImmunoResearch
(West Grove, PA, USA)
1:500
Biotinylated donkey anti-guinea-pig IgG Catalog # 705-065-147; Jackson ImmunoResearch
(West Grove, PA, USA)
1:500
FITC-donkey anti-guinea-pig IgG Catalog # 706-095-148; Jackson ImmunoResearch
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terminal were in the same focal plane.
Immunoﬂuorescently stained brainstem sections from
the caudal tip of the 4th ventricle to the spinomedullary
junction were examined with an Olympus AX70
epiﬂuorescence microscope ﬁtted with a single-
wavelength LED illumination system and emission ﬁlters
that unequivocally distinguished red and green
ﬂuorophores without bleed-through. For FITC, the
excitation wavelength was 490 nm; and the emission
wavelengths, 515–545 nm. For Cy3, wavelengths were
525 nm for excitation and 575–615 nm for emission.
We used a SPOT Insight Model 18.2 ﬁrewire color
camera and SPOT RT software version 4.6 (Diagnostic
Instruments Inc., Sterling Heights, MI, USA) to collect
digital images of immunoperoxidase-stained spinal
neurons. Images of immunoﬂuorescently stained
brainstem neurons were captured with an Orca high-
resolution cooled CCD digital camera (Hamamatsu,
Hamamatsu City, Japan) and analySIS ruler software
(version 5; Soft Imaging Solutions, an aﬃliate of
Olympus, Olympus Soft Imaging Solutions GmbH,
Mu¨nster, Germany). We used Adobe PhotoShop to
adjust the sharpness, brightness, and contrast of images
saved as TIFF ﬁles, to match the color of the digital
images and to prepare montages and plates.Counting spinal YFP-immunoreactive neurons that
project rostrally. We determined whether YFP-
immunoreactive neurons in the lumbar enlargement (LE)
projected rostrally in 1:3 series of immunoperoxidase-
stained transverse sections from two female YFP-PPG
mice. We examined every section in the series and
classed each brown YFP-immunoreactive soma as
either positive or negative for the presence of black
perinuclear puncta due to retrograde transport of FG
from injections at T9.Counting spinal neurons with YFP-immunoreactive
appositions. Parasympathetic preganglionic neurons
(PPN): We used our published counting strategy
(Llewellyn-Smith et al., 2013) to determine the proportion
of sacral PPN that received YFP-PPG innervation. Brown
ChAT-immunoreactive PPN in the sacral parasympathetic
nucleus were examined for close appositions provided by
black YFP-immunoreactive axons in alternate 25-lm
horizontal sections from two male YFP-PPG mice. The
parasympathetic nucleus was photographed at 10
magniﬁcation. In PhotoShop, the resulting TIFFS were
montaged and two new layers were added to the montage.
Using a 100 oil immersion lens, we then inspected each
PPN to determine whether any YFP-immunoreactive
boutons apposed it. Using the pencil tool on one of the
new PhotoShop layers, we marked the position of each
neuron that received a YFP apposition with a blue dot.
We marked the position of each neuron without any YFP
appositions on the second layer with a red dot. To count
PPN that did or did not receive close appositions from
YFP-positive terminals, the layers with colored dots were
saved as individual TIFF ﬁles. After opening each TIFF ﬁle
in ImageJ (National Institutes of Health), we converted theimage to black and white and used the Analyze Particle
function to count dots.
Spinal YFP-immunoreactive neurons: Black YFP-
immunoreactive neurons in the dorsal horn of the LE
from seven mice were located in 1:3 or 1:6 series of
sections stained for YFP plus ChAT and in 1:6 series of
sections stained for YFP plus NOS. In each series of
sections, we examined every YFP-expressing spinal
neuron with a 100 oil immersion objective to determine
if it received close appositions (see criteria above) from
YFP-immunoreactive terminals. In sections immuno-
stained for YFP plus ChAT, spinal YFP-positive neurons
were checked for the presence of close appositions
from axons immunoreactive for ChAT. We assessed
whether or not NOS-immunoreactive axons closely
apposed YFP-labeled neurons in sections stained for
YFP plus NOS.Counting brainstem YFP-PPG neurons that project to
the spinal cord. In one male mouse and two female mice
with FG injections at T9, we examined green YFP-
immunoreactive cell bodies in the NTS, IRT and midline
for the presence of FG-immunoreactivity that had
been retrogradely transported from the spinal cord.
From each mouse, we collected digital images of all
sections containing YFP-immunoreactive neurons from
the NTS and IRT on one side of the brainstem or from
the midline. Since medullas were sectioned into 1:3
series, 60 lm separated photographed sections. YFP-
immunoreactive neurons were counted unilaterally in a
total of 19 sections through the NTS and 18 sections
through the IRT and in 13 sections through the midline.
To determine the proportion of YFP-PPG neurons
that were spinally-projecting, we photographed green
YFP-immunoreactive neurons in a region using a x10
objective and then photographed red FG-immunoreactive
neurons in the same region. The two micrographs as
TIFF ﬁles were false-colored appropriately and then
overlaid in PhotoShop. Green YFP neurons were
checked for the presence of red intracellular FG
staining. The positions of neurons double-labeled for
YFP and FG were marked with blue dots using the
pencil tool on one new PhotoShop layer and the
positions of neurons single-labeled for YFP were
marked with magenta dots on a second new layer. To
count YFP neurons with or without FG labeling, the two
layers were saved as separate TIFF ﬁles, opened in
ImageJ and converted to black and white. The Analyze
Particle function was then used to count the dots. Data
are presented as mean ± standard error (SEM).RESULTS
Native YFP ﬂuorescence within the spinal cord
The distribution of glucagon promoter-driven YFP
expression in coronal and longitudinal sections of spinal
cord between thoracic segment 1 (T1) and sacral
segment 4 (S4) was assessed in seven adult YFP-PPG
mice. ‘Native’ YFP-ﬂuorescence was strong and both
YFP-ﬂuorescent axons and cell bodies could be
Fig. 1. Distribution of spinal axons showing native YFP ﬂuorescence in segments L3-S1. (A) Schematic showing the locations of YFP-ﬂuorescent
axons and cell bodies in longitudinal sections through the lower lumbar and upper sacral spinal cord at dorsoventral levels indicated in the diagram
of the transverse section, which shows L3 (modiﬁed from the Allen Brain Institute Reference Atlas; http://mousespinal.brain-map.org/imageseries/
showref.html). (B) In the lower lumbar cord, YFP-ﬂuorescent nerve cell bodies (arrows) as well as YFP-ﬂuorescent varicose and non-varicose axons
occur within the deep dorsal horn (DH). (C) In dorsal lamina X, YFP-ﬂuorescent axons travel rostrocaudally and mediolaterally. A rostrocaudal tract
of varicose YFP-ﬂuorescent axons (stars) lies just dorsal to the central canal. Scale bars: B and C= 100 lm.
Fig. 2. YFP-immunoreactive cell bodies and dendrites at the level of the lumbar enlargement (LE). Two-color immunoperoxidase staining for YFP
(black) and ChAT (brown) in transverse sections through the lower lumbar spinal cord. (A) A YFP-immunoreactive cell body (black) in lamina V of
the dorsal horn (DH) at spinal level L4–5. ChAT-immunoreactive somatic motor neurons (brown) occur in lamina IX in the ventral horn (VH). The
arrow indicates the location of the neuron shown in B. cc, central canal. Montage of 18 micrographs. Scale bar = 250 lm. (B) Higher magniﬁcation
image of the black YFP-immunoreactive neuron indicated by B in A. The boxed area is shown at higher magniﬁcation in Fig. 9A. Montage of 9
micrographs. (C and D) Other examples of black YFP-immunoreactive cell bodies and their dendrites in lamina V of the lumbar enlargement. (D)
Montage of 2 micrographs. Scale bars in B–D, 50 lm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
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observed in brainstem (Hisadome et al., 2010; Llewellyn-
Smith et al., 2011).YFP-immunoreactive cell bodies and dendrites within
the spinal cord
Although native YFP ﬂuorescence (Fig. 1) revealed that
YFP-expressing neurons existed in the lumbosacral
spinal cord, an anti-GFP antibody with peroxidase
detection was better for deﬁning the morphology of thespinal YFP-positive neurons (Fig. 2). YFP-
immunoreactive cell bodies were present in the deep
dorsal horn (laminae IV and V) and were located mainly
in the LE. The segmental distribution of YFP-positive
spinal neurons never overlapped with the segmental
distribution of sympathetic preganglionic neurons (SPN).
However, rare YFP-expressing neurons occurred in the
same sections as the most rostrally located PPN. The
spinal YFP-immunoreactive neurons had fusiform or
multipolar cell bodies and a small number of dendrites
with few branches. The best-stained YFP-positive
Fig. 3. Spinal YFP-immunoreactive neurons do not project rostrally. (A) Transverse section single-stained to show FG-immunoreactivity at the
center of an FG injection site (star) in thoracic segment T9. Peroxidase reaction product occurs throughout the spinal gray and white matter. Thus, it
is highly likely that all axons passing through the injection site have taken up FG. Montage of 6 micrographs. Scale bar = 250 lm. (B) Two-color
immunoperoxidase staining for FG (black) and YFP (brown). Four brown YFP-immunoreactive cell bodies in the lumbar enlargement (LE) lack black
FG-immunoreactivity, indicating that they do not project rostrally through T9. In contrast, black puncta of FG-immunoreactivity are present in nearby
cell bodies (arrows) and in black, varicose axons of undeﬁned neurochemical phenotype. Montage of 3 micrographs. Scale bar = 50 lm. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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both laterally and dorsally. The primary and secondary
dendrites of YFP-immunoreactive neurons generally
were smooth but a few intensely stained dendrites
exhibited small dendritic spines. The somata of a
number of the heavily stained YFP-expressing neurons
gave rise to very ﬁne processes that traveled for
variable distances without changing diameter, a
morphology that is suggestive of axons.
Spinal injections of the retrograde tracer FG in ﬁve mice
and subsequent immunoperoxidase processing of cords to
detect FG-immunoreactivity allowed us to assess whether
spinal YFP-expressing neurons in the LE sent axons to
the brain (Fig. 3). The FG injection sites (Fig. 3A) were
centered on the IML between segments T8 and T10.
FG-immunoreactivity spread throughout the spinal gray
and white matter for one to two segments in both rostral
and caudal directions. To quantify the proportion of spinal
YFP-containing neurons that sent axons through the T9
injection sites, we used double immunoperoxidase
staining to localize FG (black) and YFP (brown) in
transverse sections from two mice (Fig. 3B) and counted
neurons that were single-stained for YFP or double-stained
for YFP+ FG. We examined 55 YFP-immunoreactive
neurons in one mouse and 43 in the other mouse. Although
neurons retrogradely labeled with FG lay very near to the
YFP-expressing neurons (Fig. 3B), not one of the 98 spinal
YFP-immunoreactive neurons that we examined showed
immunoreactivity for FG.Distribution of YFP-immunoreactive axons within the
spinal cord
After immunoperoxidase staining of either transverse or
horizontal sections of spinal cord, both non-varicose and
varicose YFP-PPG axons were intensely stained for YFP.
Many non-varicose YFP-immunoreactive axons
traveled rostrocaudally in white matter tracts (Fig. 4).
These axons were most dense in the ventral white
commissure and around the ventral median ﬁssure. Non-
varicose axons were also common in the lateral and
ventral funiculi in rostral thoracic segments. The densityof non-varicose axons declined progressively from rostral
to caudal segments.
Varicose YFP-containing axons had clearly delineated
varicosities and ﬁne intervaricose segments (Figs. 4–9).
Some of the axons had large varicosities; others had
small ﬁne varicosities and some axons had both large
and small varicosities (e.g., Figs. 6B, C and 7E). All three
types of axons made close appositions on
immunohistochemically identiﬁed spinal neurons. In
segments T1–L2 (Figs. 4 and 5), which contain SPN,
many varicose, YFP-immunoreactive axons traveled
rostrocaudally along the IML and mediolaterally between
the IML and the intercalated nucleus (ICN). There was
also a dense plexus of varicose axons containing YFP-
immunoreactivity that ran rostrocaudally through the
dorsal portion of lamina X, the location of SPN cell bodies
in the spinal autonomic subnucleus called the central
autonomic area (CAA). Smaller numbers of varicose
YFP-positive axons occurred through lamina VII and in
laminae VIII and IX; areas containing limb motor neurons
(Figs. 4D and 7). There were fewer immunoreactive
axons in laminae IV and V than in laminae containing
autonomic and somatic motor neurons (Fig. 4A, E). The
number of YFP-containing axons decreased from lamina
IV to lamina II, where there were almost no YFP-
immunoreactive axons. YFP-positive axons were never
found in lamina I.YFP-immunoreactive innervation of spinal
cholinergic neurons
We assessed the YFP innervation of spinal cholinergic
neurons using two-color immunoperoxidase labeling in
transverse and horizontal sections from spinal segments
T1–S4. YFP-immunoreactive axons were detected with
anti-GFP and a black peroxidase reaction product.
Cholinergic neurons were revealed by immunoreactivity
for ChAT, the acetylcholine synthesizing enzyme, and a
brown reaction product. ChAT-positive neurons in the
lateral horn of spinal segments T1–L2 were classiﬁed as
SPN. Their cell bodies were concentrated in the IML and
in the CAA above the central canal (i.e., dorsal lamina X).
Fig. 4. Distribution of YFP-PPG axons in thoracic spinal cord. Two-color immunoperoxidase staining for YFP (black) and ChAT (brown) in
transverse sections through the thoracic spinal cord. (A–D) In spinal segments T5–6, there is a high density of rostrocaudally running black YFP-
immunoreactive axons in the lateral funiculus (LF; C). There are close appositions between black YFP-immunoreactive varicosities and brown
ChAT-immunoreactive sympathetic preganglionic neurons (SPN) in the intercalated nucleus (ICN; B) and brown ChAT-immunoreactive somatic
motor neurons in the ventral horn (VH; D). A higher magniﬁcation image of the cell body indicated by the double arrowheads in A and D is shown in
Fig. 7I. (E and F) Brown ChAT-immunoreactive SPN in the intermediolateral cell column (IML) of T3–4 receive close appositions (arrows) from black
YFP-immunoreactive varicosities. (G and H) In the central autonomic area (CAA) at T9–10, black YFP-immunoreactive varicosities (black) also form
appositions (arrows) on brown ChAT-immunoreactive SPN. cc, central canal. Micrographs in montages: A and E, 5; B, 6; C and D, 3; F & H, 2; G, 4.
Scale bars: A and E, 100 lm; C, D and G, 50 lm; B, F and H, 20 lm. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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contained SPN somata and a few SPN cells bodies were
present in the dorsolateral funiculus. ChAT-immunoreactive
neurons located in the spinal parasympathetic nucleus in
the lateral horn of the lower lumbar and upper sacral cord
were classiﬁed as PPN. ChAT-immunoreactive neurons
lying in the ventral horn at any spinal level were considered
to be somatic motor neurons.Innervation of SPN
In both transverse (Fig. 4) and horizontal (Fig. 5) sections,
it was clear that the YFP innervation of the CAA was
considerably more dense than the YFP innervation of
either the IML or the ICN. There were also YFP-
immunoreactive axons in the dorsolateral and lateral
funiculi (Figs. 4A–E and 5A, B). Many of the varicoseYFP-immunoreactive axons in the IML and ICN in spinal
segments T1–L2 closely apposed the cell bodies and
proximal dendrites of ChAT-immunoreactive SPN
(Fig. 4A, B, E and F). Similarly, varicose YFP-positive
axons in dorsal lamina X often formed close appositions
on ChAT-positive SPN perikarya in the CAA (Figs. 4G,
H and 5D–F). In both the IML and CAA, some
ChAT-positive neurons received more than one
apposition from YFP-immunoreactive terminals. This
was particularly the case for SPN that lay within dense
arrays of YFP-positive axons (Fig. 4B, H).Innervation of PPN
In transverse sections through the parasympathetic
nucleus in segments L6 and S1, it was diﬃcult to ﬁnd
YFP-immunoreactive terminals that closely apposed
Fig. 5. YFP-immunoreactive innervation of sympathetic preganglionic neurons (SPN). Two-color immunoperoxidase staining for YFP (black) and
ChAT (brown) in horizontal sections through the spinal cord at upper thoracic (Upper T; A and B) and lower thoracic/upper lumbar (Lower T/Upper L;
C) levels. At both spinal levels (B and C), black YFP-immunoreactive axons most densely innervate the central autonomic area (CAA), which lies
dorsal to the central canal (cc) in lamina X. The intermediolateral cell column (IML) receives a moderately dense black YFP innervation. The lateral
funiculus (LF; A and B) contains primarily black YFP-immunoreactive axons of passage that run rostrocaudally and occasional axons that travel
mediolaterally (small arrows in A). The neurons indicated by arrows D–F are shown at higher magniﬁcation in D–F. Micrographs in montages: A, 3;
B, 9; C, 6. (D–F) Black YFP-immunoreactive boutons from close appositions (arrows) on brown ChAT-immunoreactive SPN in the CAA. E, Montage
of 2 micrographs. Scale bars: A–C, 100 lm; D–F, 20 lm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to
the web version of this article.)
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were much easier to ﬁnd in horizontal sections (Fig. 6)
but appositions were still uncommon. In horizontal
sections, it was possible for us to determine the
proportion of the PPN population that received YFP
innervation. We examined a total of 948 PPN in two
mice. In one mouse, YFP-immunoreactive varicosities
closely apposed 64 of 502 PPN (12.8%); in the other
mouse, 55 of 446 PPN (12.3%) received YFP-positive
close appositions. In all cases, only one YFP-containing
terminal apposed each innervated PPN.Innervation of somatic motor neurons
In transverse sections of T1–S4, the vast majority of
ChAT-immunoreactive motor neurons in the ventral
horn lacked YFP innervation (Fig. 7) although
YFP-immunoreactive boutons did form close appositionson the cell bodies of rare ChAT-positive motor neurons
(Fig. 7F–I). Appositions were also found on motor
neuronal dendrites (Fig. 7E) but such axodendritic
appositions were even less common than axosomatic
appositions.
YFP-immunoreactive innervation of neurons that
contain NOS
We have previously shown that in IML and CAA, both SPN
and interneurons contain immunoreactivity for NOS, the
enzyme that synthesizes nitric oxide (Hinrichs and
Llewellyn-Smith, 2009). To determine whether YFP-PPG
neurons innervated spinal interneurons as well as SPN,
we retrogradely labeled the entire population of SPN via
intraperitoneal injections of FG (Anderson and
Edwards, 1994) and then used triple immunoperoxidase
labeling to localize YFP (black), FG (black) and NOS
(brown) in horizontal sections of spinal cord (Fig. 8).
Fig. 6. YFP-immunoreactive innervation of parasympathetic preganglionic neurons (PPN). Two-color immunoperoxidase staining for YFP (black)
and ChAT (brown) in a horizontal section through the lumbosacral (L6-S1) spinal cord. (A) The sacral parasympathetic nucleus (PN) is sparsely
innervated by black YFP-immunoreactive axons. Of the 133 PPN in A, black YFP-positive axon terminals closely appose only 29 of the brown
ChAT-immunoreactive PPN, some of which are indicated by arrows. Arrows B-E mark neurons that are shown at higher magniﬁcation in B–E. Black,
non-varicose YFP-immunoreactive axons run rostrocaudally through the white matter of the lateral funiculus (LF). Asterisks indicate the lateral edge
of the spinal cord. Montage of 6 micrographs. Scale bar: 100 lm. (B–F) Brown ChAT-immunoreactive PPN receive close appositions (arrows) from
black YFP-immunoreactive varicosities. Micrographs in montages: B, 4; C, 3; D and E, 2; F, 6. Scale bars: 10 lm. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 7. YFP-immunoreactive innervation of somatic motor neurons. Two-color immunoperoxidase staining for YFP (black) and ChAT (brown) in
transverse sections through the thoracic and lumbar spinal cord. (A–C) At all segmental levels, lamina IX contains a moderate number of black
varicose YFP-immunoreactive axons. Micrographs in montages: A, 3; B and C, 5. Scale bars: A and B, 100 lm; C, 250 lm. (D–I) Nevertheless, only
rare, brown ChAT-immunoreactive somatic motor neurons receive close appositions (arrows) from black YFP-immunoreactive varicosities.
Appositions from YFP-immunoreactive boutons do occur on the dendrites of somatic motor neurons (C–E). However, in most cases, YFP-
containing varicosities appose the cell bodies of somatic motor neurons (F–I). LE, lumbar enlargement. Micrographs in montages: D-F & H, 3; G, 2;
I, 5. Scale bars: D, 50 lm; E–I, 20 lm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
this article.)
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Fig. 8. YFP-immunoreactive innervation of nitric oxide synthase (NOS)-immunoreactive spinal neurons. Triple immunoperoxidase staining for YFP
(black), intraperitoneal FG (black) and NOS (brown) in the IML and CAA. Neurons containing FG-immunoreactivity send axons to the periphery and
neurons without FG have axons that stay within the CNS. Hence, FG staining distinguishes between NOS-positive interneurons and NOS-positive
SPN. Both NOS-containing SPN and NOS-containing spinal interneurons receive input from YFP-immunoreactive axons. (A and B) In the IML, SPN
showing immunoreactivity for NOS (brown) and FG (black puncta within the cytoplasm) receive close appositions (arrows) from black YFP-
immunoreactive boutons. A, Montage of 2 micrographs. Scale bars: 20 lm. (C) Similarly in the CAA, black YFP-immunoreactive varicosities closely
appose (arrows) neurons that contain both brown NOS- and black FG-immunoreactivity, indicating that they are SPN. Asterisk, Ependymal cells
lining the dorsal surface of the central canal are out of focus. Montage of 2 micrographs. Scale bar: 20 lm. (D) In the CAA, a varicosity from a black
YFP-positive axon closely apposes (arrow) a brown NOS-positive neuron that lacks FG-immunoreactivity, indicating that it is an interneuron. Nearby
neurons (stars) contain black FG-immunoreactive puncta, indicating that they are SPN. The top starred SPN is faintly immunoreactive for NOS.
Montage of 5 micrographs. Scale bar: 20 lm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
Fig. 9. Innervation of spinal YFP-immunoreactive neurons. Two-color immunoperoxidase staining for YFP (black) and ChAT (brown) in transverse
sections through the lumbar enlargement. (A) A YFP-immunoreactive axon forms several close appositions (arrows) on the dendrite of the
YFP-immunoreactive spinal neuron shown in Fig. 2B. (B) A YFP-immunoreactive varicosity apposes (arrow) the proximal dendrite of a
YFP-immunoreactive spinal neuron. (C) The cell body of a YFP-immunoreactive spinal neuron receives a close apposition (arrow) from a YFP-
immunoreactive varicosity. (D) The dendrite of a YFP-positive spinal neuron receives a close apposition from a YFP-positive bouton (arrow) as well
as from several ChAT-positive boutons (double arrowheads). Micrographs in montages: A, 12; D, 3. Scale bars: 20 lm. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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neuronswhereas those expressingNOSplus FGwere pre-
sumed to be SPN.
In the IML, many neurons were immunoreactive for
NOS and FG or FG alone (i.e., NOS-positive and NOS-
negative SPN, respectively) whereas neurons that were
immunoreactive for NOS alone (i.e., NOS-positive
interneurons) were uncommon. The CAA contained
substantial populations of NOS/FG neurons, FG only
neurons and NOS only neurons. In the IML, YFP-
immunoreactive varicosities closely apposed NOS/FG
neurons (Fig. 8A, B). In the CAA, both NOS/FG neurons
(Fig. 8C) and NOS only neurons (Fig. 8D) received
close appositions from YFP-positive terminals. We couldnot determine whether YFP-positive axons innervated
FG only neurons because we could not deﬁne the
boundaries of neurons that contained only black
intracellular punctate labeling for FG (Fig. 8D).
YFP-immunoreactive innervation of spinal
YFP-immunoreactive neurons
In the LE, YFP-immunoreactive boutons formed close
appositions on the somata or proximal dendrites of a
subset of the spinal neurons that contained YFP
(Fig. 9A–D). To assess the extent of this innervation, we
counted YFP-immunoreactive neurons that were and
were not apposed by YFP-immunoreactive axons in
transverse sections that were stained for YFP and either
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YFP-expressing spinal neurons examined, 40 (20.5%)
received close appositions from YFP-immunoreactive
terminals.
Because the sections assessed for YFP appositions
were double-stained for YFP plus a neurotransmitter-
related marker, we were able to determine whether or
not YFP-expressing spinal neurons received innervation
from ChAT- or NOS-immunoreactive axons. ChAT-
positive boutons closely apposed 23% (32 of 139) of the
YFP-immunoreactive spinal neurons in sections stained
for YFP plus ChAT with many of the innervated neurons
receiving several appositions from ChAT-positive
terminals (Figs. 9D). YFP-immunoreactive boutons also
apposed ﬁve of the 32 YFP-immunoreactive spinal
neurons with ChAT innervation (Fig. 9D). In contrast,
none of the 56 YFP-immunoreactive spinal neurons in
sections stained for YFP plus NOS were closely
apposed by NOS-positive boutons.
Source of spinal PPG innervation
As reported previously (Llewellyn-Smith et al., 2011,
2013), we observed YFP-immunoreactive cell bodies in
the caudal NTS and the medial portion of the IRT and in
the midline (Fig. 10). In the caudal NTS, YFP-PPG
somata extended from caudal to the caudal tip of the area
postrema (AP) to roughly mid-AP level. At the caudal end
of their distribution within the NTS, the YFP-PPG neurons
were located medially whereas at the rostral end, they
were mainly found laterally. Within the IRT, YFP-immuno-
reactive somata occurred from about mid-AP level to
roughly where the NTS moved away from the fourth ven-
tricle in a location that is dorsomedial to the nucleus
ambiguus and the A1 cell group. In the midline, a few
YFP-immunoreactive somata lay just ventral to theFig. 10. Spinally projecting YFP-PPG neurons in the brainstem. Double immu
of YFP-PPG mice that received injections of FG at spinal segment T9. The
immunoﬂuorescent neurons (A–C), some of which contain FG-immunoreactiv
PPG neurons. A’’, B’’, C’’, merged images of micrographs showing YFP- and
C, 50 lm. (For interpretation of the references to color in this ﬁgure legend,hypoglossal nucleus in the region equivalent to raphe´
obscurus (Fig. 10).
In mice with injections of the retrograde tracer FG into
spinal segment T9, we found that many of the green YFP-
immunoﬂuorescent neurons in the brainstem also
contained red FG immunoﬂuorescence, indicating that
their axons projected to the spinal cord. YFP-PPG
neuron containing FG-immunoreactivity occurred not
only in the NTS (Fig. 7A–A’’) and IRT (Fig. 7B–B’’) but
also in the midline (Fig. 7C–C’’).
We examined 614 medullary YFP-PPG neurons (416
NTS neurons, 149 IRT neurons and 49 midline neurons) in
three mice for the presence of FG retrogradely transported
from the spinal cord. Quantiﬁcation of neurons double-
stained for YFP and FG and single-stained for YFP
showed that, overall, 353 of the 614 (57.5%) medullary
YFP-PPG neurons contained FG-immunoreactivity. YFP-
immunoreactive/FG-immunoreactive neurons occurred in
all medullary regions that contained YFP-PPG neurons.
Immunoreactivity for FG was found in 53.8± 10.6% of
YFP-immunoreactive neurons in the NTS (231/416
neurons), 61.5± 6.3% of YFP-PPG neurons in the IRT
(96/149 neurons) and 53.1 ± 4.3% of YFP-PPG neurons
in the midline (26/49 neurons).DISCUSSION
Here, we assessed the PPG innervation of
neurochemically identiﬁed spinal neurons in YFP-PPG
mice (Reimann et al., 2008; Llewellyn-Smith et al.,
2011). In these mice YFP is expressed selectively in cells
where the glucagon promoter is active (Reimann et al.,
2008; Hisadome et al., 2010). Consequently, these mice
show YFP-immunoreactivity exclusively in pancreatic
a-cells that produce glucagon and enteroendocrinenoﬂuorescent staining for YFP (green) and FG (red) in the brainstems
NTS (A–A’’), the IRT (B–B’’) and dorsal midline (C–C’’) contain YFP-
ity (A’, B’ and C’). Double labeled neurons are spinally projecting YFP-
FG-immunoreactive neurons in each area. Scale bars: A, B, 100 lm;
the reader is referred to the web version of this article.)
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GLP-1 and GLP-2 (Reimann et al., 2008). YFP-express-
ing neurons in YFP-PPG mice produce PPG mRNA, as
demonstrated by single-cell RT-PCR for YFP-PPG
neurons in the NTS (Hisadome et al., 2010, 2011), and
should therefore synthesize GLP-1 and GLP-2 in addition
to YFP.
Descending projections from brainstem PPG
neurons
Previous studies have demonstrated that GLP-1-immuno-
reactive neurons located in the caudal NTS and the IRT
send ascending projections to forebrain targets,
including the DMH and the PVN (Vrang et al., 2007), as
well as the ventral tegmental area and the nucleus
accumbens (Dossat et al., 2011; Alhadeﬀ et al., 2012).
PPG neurons in the medulla also project locally to cholin-
ergic and catecholaminergic neurons in the NTS and the
DMV and to monoaminergic neurons in the ventral
medulla (Llewellyn-Smith et al., 2013). However, little is
known about descending GLP-1 projections to the spinal
cord (Maniscalco et al., 2012).
The results of this study show for the ﬁrst time that the
spinal cords of YFP-PPG mice receive a substantial PPG
innervation. Similar to our previous observations in the
brain, we found that the highest densities of varicose
YFP-immunoreactive axons occurred in some of the
autonomic areas of the spinal cord. Speciﬁcally, spinal
YFP innervation was preferentially targeted toward the
CAA (i.e., dorsal lamina X) and the IML, areas that
contain the cell bodies of SPN. In contrast, the sacral
parasympathetic nucleus, which contains the cell bodies
of PPN, was sparsely innervated. YFP-positive axons
were moderately dense in laminae V, VIII and IX. The
density of YFP innervation declined from lamina V to
lamina II and we never observed a YFP-containing axon
in lamina I. This distribution of YFP-PPG axons matches
the distribution of neurons expressing the GLP-1
receptor in rat spinal cord (Merchenthaler et al., 1999),
which were located in the ventral horn but not the dorsal
horn (Merchenthaler et al., 1999).
The results of our retrograde tracing from spinal
segment T9 have demonstrated that a substantial
fraction of brainstem YFP-PPG neurons send axons to
the spinal cord. Similar to PPG projections to the
hypothalamus (Vrang et al., 2007), we found that YFP-
PPG neurons located in the NTS, IRT and midline all pro-
jected to the spinal cord, suggesting there is no spatial
segregation within the medulla of PPG neurons that inner-
vate diﬀerent targets. We have shown here that at least
half of YFP-PPG neurons in the medulla have descending
axons that reach the lower thoracic spinal cord. Sizeable
proportions of PPG neurons are also known to project to
hypothalamic sites (Vrang et al., 2007), to the nucleus
accumbens (Dossat et al., 2011; Alhadeﬀ et al., 2012)
and to the ventral tegmental area (Alhadeﬀ et al., 2012).
Taken together, these observations suggest that individ-
ual PPG neurons might project to more than one target.
YFP-immunoreactive neurons in the LE
One of the most surprising ﬁndings of this study was
the discovery of a small, distinct population ofYFP-immunoreactive neurons in the deep dorsal horn of
the lower lumbar spinal cord. Unlike the PPG neurons in
the NTS, we are currently unable to access these neurons
for single-cell RT-PCR analysis in vitro. Thus, we cannot
entirely exclude the possibility that these neurons
express the YFP transgene ectopically, a problem that
occasionally occurs in transgenic animals. Nevertheless,
performing RT-PCR on RNA isolated from lumbosacral
spinal cord allowed us to demonstrate the presence of
PPG mRNA in this spinal region (Trapp, Manton,
Edwards, unpublished observations). This ﬁnding
supports the hypothesis that spinal YFP-PPG neurons
do, in fact, produce GLP-1 although it is conceivably
possible that the PCR signal might be due to mRNA in
axons originating from YFP-PPG neurons in the NTS.
At present, the functional role of the YFP-
immunoreactive neurons in the LE is unclear. Our
injections of FG into T9 clearly show that these spinal
YFP-positive neurons do not have axons that travel
through the lower thoracic cord. Hence, the spinal YFP-
synthesizing neurons do not project rostrally and
therefore do not provide any of the innervation that we
have previously described in the brain (Llewellyn-Smith
et al., 2011, 2013). When we applied FG intraperitoneally,
intraspinal YFP-immunoreactive neurons also failed to
label. Hence, the axons of these neurons do not leave
the spinal cord so their innervation targets must be within
the CNS. It is possible that the spinal neurons expressing
YFP project locally, possibly to PPN or to spinal interneu-
rons that are part of spinal parasympathetic circuitry. Our
experiments did not explore these possibilities.
PPG innervation of ChAT and NOS immunoreactive
spinal neurons
The spinal cord contains three major populations of ChAT-
immunoreactive cholinergic neurons. These areSPN,PPN
and somatic motor neurons. Our current study has
demonstrated that, of these three functionally distinct
groups of spinal neurons, SPN receive by far the highest
density of close appositions from varicosities of YFP-
PPG axons. We also found that the CAA, which contains
many of the SPN projecting to the celiac, inferior
mesenteric and major pelvic ganglia (Fenwick et al.,
2006; Hinrichs and Llewellyn-Smith, 2009), was more
heavily innervated by YFP-immunoreactive axons than
the IML. Unlike SPN, PPN in the sacral parasympathetic
nucleus received a meagre GLP-1 innervation, with YFP-
PPG axons closely apposing only about 10% of these neu-
rons. The GLP-1 input to somatic motor neurons was even
sparser; only rare ChAT-positive neurons throughout the
rostrocaudal extent of the ventral horn were closely
apposed by YFP-immunoreactive axons. We have
assumed that close appositions from YFP-containing axon
terminals signify innervation. While this assumption could
only be conﬁrmed with electron microscopy, ultrastructural
studies on other central autonomic neurons by Pilowsky
et al. (1992) have veriﬁed that at least half of the terminals
that form close appositions at the light microscope level
form synaptic contacts at the ultrastructural level.
Furthermore, electron microscopy has recently conﬁrmed
that GLP-1 neurons form synapses in the CNS with the
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axon terminals onto dendrites in rat hypothalamus
(Zheng et al., 2014).
NOS-immunoreactive interneurons also occur in the
CAA (Hinrichs and Llewellyn-Smith, 2009) so we investi-
gated whether CAA interneurons received PPG innerva-
tion. In mice with intraperitoneal FG injections, which
are known to label all SPN (Anderson and Edwards,
1994), we classiﬁed NOS-immunoreactive neurons in
the CAA as interneurons if they lacked FG-immunostain-
ing. We found that many of the NOS-positive/FG-negative
CAA neurons received close appositions from YFP-immu-
noreactive axons, indicating that spinal interneurons as
well as SPN are targeted by the spinal axons of brainstem
PPG neurons.
Taken together, our observations show that, in the
spinal cord, PPG innervation is preferentially directed
toward SPN, with SPN in the CAA being more heavily
innervated than SPN in the IML or ICN. In contrast,
PPG axons only lightly innervate the spinal
parasympathetic preganglionic population. Whether
PPG axons target a speciﬁc functional subset of PPN
will require experiments using transynaptic viral labeling
or functional neuroanatomical approaches. ChAT-
positive neurons in the ventral horn received by far the
lightest PPG input. This input is so miniscule that
activation of brainstem PPG neurons is very unlikely to
aﬀect the activity of somatic motor neurons.
Central PPG neurons in the control of autonomic
functions
Neurons in the NTS are generally thought to inﬂuence
sympathetic outﬂow indirectly through a relay in the
ventral medulla or through ascending projections to
hypothalamic nuclei that provide direct input to SPN in
the spinal cord. Although medullary PPG neurons might
be part of such bulbospinal or hypothalamic-spinal
pathways (Llewellyn-Smith et al., 2011, 2013), the pres-
ent study demonstrates that there is a substantial direct
projection from PPG neurons in the NTS, IRT and midline
to spinal sympathetic nuclei. Spinally projecting neurons
in the NTS and IRT have been reported in the rat (Mtui
et al., 1993). The striking similarity in the distribution of
NTS and IRT neurons projecting to the spinal cord in that
study with the distribution of spinally projecting YFP-PPG
neurons found here suggests that PPG neurons might
constitute a sizeable fraction of the NTS and IRT neurons
that supply axons to the spinal cord. Furthermore, a good
proportion of the spinally projecting NTS neurons found
by Mtui et al. (1993) had terminals in the CAA in addition
to the IML, similar to our observations here.
Gastrointestinal function
The present study has demonstrated a dense PPG
innervation of SPN, particularly SPN whose cell bodies
lie in the CAA. The CAA contains many SPN that
project to prevertebral ganglia, including the celiac,
mesenteric and major pelvic ganglia (Fenwick et al.,
2006; Hinrichs and Llewellyn-Smith, 2009). Since sympa-
thetic post-ganglionic neurons in these ganglia innervate
the entirety of the gastrointestinal tract from the stomachto the rectum (Keast and de Groat, 1989; Dhami and
Mitchell, 1994; Domoto and Tsumori, 1994; Trudrung
et al., 1994; Quinson et al., 2001), GLP-1 input to SPN
could modulate sympathetic outﬂow to every section of
the gut. The celiac and superior mesenteric ganglia have
been shown to contain SPN that are part of the circuitry
controlling splanchnic blood vessels (Macrae et al.,
1986; Hsieh et al., 2000). If PPG axons target SPN in cir-
cuits controlling the mesenteric vasculature, then PPG
neurons in the medulla could inﬂuence not only motility,
secretion and absorption in the gut but also its blood
supply.
Cardiovascular regulation
In addition to a role in regulating gut function, brainstem
PPG neurons may also aﬀect cardiovascular control.
Anatomical ﬁndings from this and previous studies
suggest that PPG neurons could modulate sympathetic
outﬂow via descending, ascending and/or intramedullary
pathways (Rinaman, 1999; Vrang et al., 2007; Tauchi
et al., 2008; Llewellyn-Smith et al., 2011, 2013; Gu
et al., 2013). When injected intracerebroventricularly
(i.c.v.), the GLP-1 receptor agonist exendin-4 (Ex-4)
raises blood pressure and heart rate (Yamamoto et al.,
2002; Cabou et al., 2008; Hayes et al., 2008; Griﬃoen
et al., 2011). The tachycardia and hypertension in
response to 4th ventricular Ex-4 injection persist in
chronic decerebrate rats so hypothalamic GLP-1 recep-
tors are not necessary for the cardiovascular responses
(Hayes et al., 2008). However, it is not known whether
i.c.v. Ex-4 reaches GLP-1 receptors located on SPN in
the CAA or IML or CAA interneurons or whether intrathe-
cal injections of Ex-4 have similar cardiovascular eﬀects
to i.c.v. injections. Studies addressing these questions
would help to deﬁne the cardiovascular actions of
centrally-administered GLP-1.
Thermoregulation
Central GLP-1 can also aﬀect thermoregulatory
responses. However, both the pathways involved and
the direction of the eﬀect are still under discussion. A
number of studies have reported hypothermic eﬀects of
GLP-1 receptor agonists injected into the brain. For
instance, Hayes et al. (2008) reported Ex-4 injection into
the fourth ventricle caused hypothermia in rat. Similarly,
blockade of hindbrain GLP-1 receptor with exendin-9 pre-
vents CART-induced hypothermia (Skibicka et al., 2009).
Conversely, Osaka et al. (2005) observed an increase in
core temperature in response to GLP-1; and Lockie and
colleagues (2012) reported that i.c.v. infusion of GLP-1
caused an increase in temperature in brown adipose tis-
sue in mice. We have previously described PPG innerva-
tion of serotonin synthesizing neurons in raphe´ pallidus
(Llewellyn-Smith et al., 2013). Because serotonin neurons
in this region are part of the circuitry that activates SPN in
the spinal cord to promote heat production from brown
adipose tissue (Morrison et al., 2008), a GLP-1 input to
raphe´-spinal 5-HT neuron could be the link between
central PPG neurons and serotonin dependent thermo-
genesis. In addition, this study suggests that medullary
PPG neurons might inﬂuence thermoregulation at the
886 I. J. Llewellyn-Smith et al. / Neuroscience 284 (2015) 872–887spinal cord level. Injection of pseudorabies virus into intra-
scapular brown fat transynaptically labels SPN in the IML
of upper thoracic cord (Oldﬁeld et al., 2002; Cano et al.,
2003) and we have shown here that SPN in this region
receive close appositions from the axons of brainstem
YFP-PPG neurons. Hence, it is possible that GLP-1
may play a role in thermoregulation at the spinal cord
level. Studies involving either intrathecal injections of
GLP-1 agonists and antagonists or activation of PPG neu-
rons in the brainstem to release GLP-1 in the spinal cord
would clarify this issue.
Electrophysiological and viral tracing studies have
identiﬁed spinal sympathetic interneurons in the CAA
(Tang et al., 2004; Deuchars et al., 2005) and we have
shown here that there is PPG innervation of CAA inter-
neurons. If the population of spinal sympathetic interneu-
rons identiﬁed by Tang et al. (2004) and Deuchars et al.
(2005) includes NOS interneurons in the CAA, then brain-
stem PPG neurons may also inﬂuence sympathetic func-
tion indirectly through inputs to spinal interneurons as well
as directly through input to SPN.Parasympathetic function
In contrast to spinal sympathetic regions, we found that
PPG innervation of PPN in the parasympathetic nucleus
in lumbosacral cord was sparse, with PPG terminals
closely apposing only about 10% of these neurons.
GLP-1 has signiﬁcant eﬀects on vagal function (Holmes
et al., 2009; Griﬃoen et al., 2011) through actions on cra-
nial PPN and it would be interesting to determine whether
there are eﬀects on one or more functional types of sacral
PPN. Trans-synaptic viral tracing would identify whether
GLP-1 input to sacral PPN could inﬂuence the control of
one or more of the pelvic organs that are the innervation
targets of the parasympathetic post-ganglionic neurons
to which sacral PPN provide input. In particular, it would
be interesting to know whether PPG innervation in the
sacral parasympathetic nucleus is directed toward PPN
in pathways controlling the lower bowel.
All of these observations suggest that brainstem PPG
neurons could directly modulate sympathetic outﬂow to a
variety of target organs through spinal inputs to SPN.
PPG neurons in the medulla could also have an indirect
eﬀect on sympathetic outﬂow through their innervation
of interneurons in the CAA. Given that PPG neurons
seem to aﬀect both sympathetic and parasympathetic
outﬂows, it is pertinent to investigate whether GLP-1
globally activates one outﬂow and inhibits the other, i.e.,
the eﬀects are synergistic. Alternatively, GLP-1 eﬀects
on sympathetic and parasympathetic outﬂows could be
independent and locally focussed.CONCLUSIONS
In summary, this study provides the ﬁrst detailed description
of the PPG innervation of neurochemically identiﬁed
neurons in the spinal cord. Our results suggest that spinal
sympathetic circuits are a main innervation target of PPG
neurons in the brainstem, which provide strong innervation
to both SPN and spinal interneurons that may be involved
in regulating sympathetic function. We also found thatmore than half of the medullary PPG neurons are spinally-
projecting. Finally, we discovered a population of neurons
in the deep dorsal horn of the lower lumbar spinal cord that
expressed YFP and may be capable of synthesizing and
releasing GLP-1. The function(s) of these spinal YFP-
immunoreactive neurons is not clear but they do not
provide any innervation to the brain. Our observations add
another level of complexity to the modulation of autonomic
outﬂow by central PPG neurons.
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